期刊
SEMINARS IN CANCER BIOLOGY
卷 83, 期 -, 页码 77-87出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2021.01.005
关键词
DNA methyltransferases; Non-small cell lung cancer; DNA methylation; Dietary phytochemicals; Demethylating agents
类别
资金
- Leverhulme Trust [RPG-2016-014]
Despite the static survival rates of NSCLC, epigenetic-based therapies targeting DNMTs and histone-modifying enzymes, as well as the combination of DNMT inhibitors with chemotherapy and immunotherapy, have shown great promise in the treatment of solid tumors. Dietary phytochemicals can also inhibit DNMTs and cancer stem cells, offering a novel and promising approach to cancer prevention and treatment.
Despite the advances in treatment using chemotherapy or targeted therapies, due to static survival rates, non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths worldwide. Epigenetic-based therapies have been developed for NSCLC by targeting DNA methyltransferases (DNMTs) and histone-modifying enzymes. However, treatment using single epigenetic agents on solid tumours has been inadequate; whereas, treatment with a combination of DNMTs inhibitors with chemotherapy and immunotherapy has shown great promise. Dietary sources of phytochemicals could also inhibit DNMTs and cancer stem cells, representing a novel and promising way to prevent and treat cancer. Herein, we will discuss the different DNMTs, DNA methylation profiling in NSCLC as well as current demethylating agents in ongoing clinical trials. Therefore, providing a concise overview of future developments in the field of epigenetic therapy in NSCLC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据